Concepedia

Kayo Takamatsu

KT

4

Publications

124

Citations

4

H-Index

2006

Active since

Affiliations

Okayama University(Current)

Okayama University of Science

Nihon University

Kobe Gakuin University

Kayo Takamatsu is an author at Okayama University specializing in pharmacotherapy, drug discovery, and medicine.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyDrug ResistanceNatural SciencesMedicinal ChemistryDrug DevelopmentOrganic Chemistry

Publications per year

2006–2008

4

Publications

4

The First Potent Subtype‐Selective Retinoid X Receptor (RXR) Agonist Possessing a 3‐Isopropoxy‐4‐isopropylphenylamino Moiety, NEt‐3IP (RXRα/β‐dual agonist)

Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji et al. · ChemMedChem · 2008 · 49 citations

Analgesic agents without gastric damage: Design and synthesis of structurally simple benzenesulfonanilide-type cyclooxygenase-1-selective inhibitors

Xiaoxia Zheng, Hiroyuki Oda, Kayo Takamatsu et al. · Bioorganic & Medicinal Chemistry · 2006 · 33 citations · Full text

Medicinal Chemistry, Gastric Damage, Pharmaceutical Science +11

Reduction of Lipophilicity at the Lipophilic Domain of RXR Agonists Enables Production of Subtype Preference: RXRα‐Preferential Agonist Possessing a Sulfonamide Moiety

Kayo Takamatsu, Atsushi Takano, Nobumasa Yakushiji et al. · ChemMedChem · 2007 · 22 citations

Pharmacotherapy, Drug Resistance, Molecular Pharmacology +16

Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity

Ken-ichi Morishita, Nobumasa Yakushiji, Fuminori Ohsawa et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 20 citations · Full text

Alkyl Sulfonamide, Biochemistry, Functional Selectivity +10

Rows per page

1–4 of 4